Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life

por Muzellec, Léa, Bourien, Héloïse, Edeline, Julien
Publicado 2021

Tivozanib for hepatocellular carcinoma: not likely a new option

por Estrade, Florian, Le Du, Fanny, Crouzet, Laurence, Bourien, Héloïse, Muzellec, Léa, Edeline, Julien
Publicado 2020

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma

por Lescure, Céline, Estrade, Florian, Pedrono, Maud, Campillo-Gimenez, Boris, Le Sourd, Samuel, Pracht, Marc, Palard, Xavier, Bourien, Héloïse, Muzellec, Léa, Uguen, Thomas, Rolland, Yan, Garin, Etienne, Edeline, Julien
Publicado 2021